|1.||Zhao, Yusheng: 1 article (03/2015)|
|2.||Wang, Chunlei: 1 article (03/2015)|
|3.||Zhu, Jian-Kang: 1 article (03/2015)|
|4.||He, Xinjian: 1 article (03/2015)|
|5.||Gong, Zhizhong: 1 article (03/2015)|
|6.||Lang, Zhaobo: 1 article (03/2015)|
|7.||Li, Xiaojie: 1 article (03/2015)|
|8.||Jin, Dan: 1 article (03/2015)|
|9.||Lai, Jinsheng: 1 article (03/2015)|
|10.||Xie, Shaojun: 1 article (03/2015)|
03/01/1990 - "For the infection studies, we grew the keratinocytes on a feeder layer of lethally irradiated PA317 retrovirus packaging cells, which produced a helper-free amphotropic retroviral vector containing the neomycin phosphotransferase (neo) gene. "
08/15/1997 - "Upon infection, these vector particles can efficiently transduce the neomycin phosphotransferase (neo) gene to the target cells. "
11/01/1995 - "To achieve a 100% deletion efficiency in target cells after ex vivo infection and drug selection, we constructed a self-activating vector that simultaneously deleted E and reconstituted the neomycin phosphotransferase gene. "
01/15/1992 - "To investigate the feasibility of this approach in a large animal model system, we subjected LTMCs from nine dogs to multiple infections with retrovirus containing the neomycin phosphotransferase gene (neo) during 21 days of culture. "
09/01/1991 - "Using SNV- and murine leukemia virus-derived retroviral vectors containing the neomycin phosphotransferase gene, we found that SNV established a provirus in HeLa and COS-7 cells as efficiently as did an amphotropic murine leukemia virus, as judged by the number of G418-resistant HeLa and COS-7 cell colonies obtained after infection and selection. "
10/01/1993 - "In initial studies, the gene for neomycin phosphotransferase was introduced into the TIL of ten patients with advanced cancer to study the survival and distribution of TIL in humans. "
11/01/2005 - "Moreover, treatment with anti-mouse CXCR-2-neutralizing Ab significantly attenuated the growth of both neomycin phosphotransferase gene-transfected and IL-17-transfected NSCLC tumors in SCID mice. "
09/01/1999 - "C3L5-Flt3L and C3L5-GMCSF had reduced in vivo growth rates (25% tumor formation each) compared with 100% tumor formation of C3L5 cells expressing only neomycin phosphotransferase (C3L5-G1N). "
08/16/1994 - "Suppression of tumor growth was also observed with cells modified to express the intracellular selectable marker neomycin phosphotransferase. "
10/01/1992 - "We have established several TIL cultures from fresh tumor samples, maintained them in long-term culture, and marked them with the neomycin phosphotransferase gene using the LNL6 retroviral vector. "
|3.||HIV Infections (HIV Infection)
01/01/1998 - "We have demonstrated in previous studies that retrovirus-mediated transfer of the herpes simplex thymidine kinase (HS-tk) and neomycin phosphotransferase (neo) genes in CD3/IL-2 stimulated primary T lymphocytes followed by G418 selection resulted in T cells retaining both interleukin-2 (IL-2) and alloresponsiveness and specifically inhibited by ganciclovir (GCV). "
|5.||Hemophilia A (Haemophilia)
|2.||antibiotic G 418
|6.||Factor VIII (Coagulation Factor VIII)
|10.||RNA (Ribonucleic Acid)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|2.||Neonatal Intensive Care